Home > Insider Trading > Filing (0001367644-21-000049)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1514588	Adam Havey	400 Professional Dr, Suite 400 Gaithersburg MD 20879	Evp, Business Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-01	17,134	$30.63	55,324	No	4	M	Direct
Common Stock	Disposition	2021-03-01	17,134	$99.62	38,190	No	4	S	Direct
Common Stock	Acquisiton	2021-03-01	20,145	$49.64	58,335	No	4	M	Direct
Common Stock	Disposition	2021-03-01	20,145	$99.02	38,190	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2021-03-01	17,134	$99.62	17,134	$30.63
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2021-03-01	20,145	$99.02	20,145	$49.64

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-02-27	No	4	M	Direct
0		2025-02-26	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25.
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99.
Vests in three equal installments beginning on the day prior to the anniversary date of the grant.